Absci (ABSI) and Owkin announced a partnership bringing together two leading AI platforms to rapidly discover and design novel therapeutics for patients. Through this strategic partnership, Absci ...
Details of the collaboration first reported by the Financial Times remain sketchy at present, but will draw on Absci’s technology to create an improved antibody therapy for an undisclosed cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback